Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 10, 2022

SELL
$5.17 - $8.65 $8,478 - $14,186
-1,640 Closed
0 $0
Q3 2021

Oct 13, 2021

BUY
$4.2 - $11.92 $6,888 - $19,548
1,640 New
1,640 $12,000
Q1 2021

Apr 12, 2021

SELL
$4.3 - $7.48 $322,500 - $561,000
-75,000 Closed
0 $0
Q4 2020

Jan 19, 2021

SELL
$4.25 - $8.14 $192,979 - $369,612
-45,407 Reduced 37.71%
75,000 $318,000
Q3 2020

Oct 09, 2020

BUY
$4.65 - $9.45 $559,892 - $1.14 Million
120,407 New
120,407 $971,000

About Edesa Biotech, Inc.


  • Ticker EDSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,462,300
  • Market Cap $27.2M
  • Description
  • Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...
More about EDSA
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.